Environmental, Social and Governance (ESG) Commitments

Investing in corporate responsibility, in line with our mission and core values, has long been a critical part of our business.

We have refined our approach to ESG over time and today are focused on three core pillars:

  • Innovating for Unmet Needs
  • Empowering People and Communities
  • Sustaining Our Shared Planet

Alongside these guiding pillars, our Corporate Responsibility Committee ensures we adhere to the highest standards of ethical conduct and transparency as we continue to deliver value in a sustainable and responsible manner.

Innovating for Unmet Needs

To us, innovation means developing therapies for the world’s most devastating diseases and going beyond the medicine through our partnerships to advance community and global health. Our efforts include:

  • Helping address the diverse needs of people impacted by HIV by researching long-acting treatment and prevention options, as well as a cure.
  • Pursuing a functional cure for hepatitis B virus.
  • Meeting the growing demand for cell therapy, with the goal of reaching 25,000+ patients by 2025.
  • Advancing new therapeutic options for cancers with high unmet needs, such as metastatic triple-negative breast cancer that disproportionately impacts Black women.
  • Ensuring that Black, Latino, women, LGBTQ+ and other underrepresented groups participate in our clinical research.
  • Combatting health inequities and other barriers to care, especially those facing historically marginalized communities.

Sustaining Our Shared Planet

We are pursuing ambitious goals to continually advance our business practices and ensure a positive impact on our planet for years to come. Spanning four focus areas – Carbon, Water, Waste and Product – our goals include:

  • Achieving net-zero operational greenhouse gas emissions by 2030 (Carbon)
  • Reducing potable water use at owned facilities by 30% compared to 2019 and achieving water neutrality in water-stressed regions by 2030 (Water)
  • Reducing total solid waste generated by 20% compared to 2019, including elimination of single use plastics (excludes R&D operations) and achieving zero waste to landfill at owned facilities programs by 2030 (Waste)
  • Ensuring 100% of our product packaging used is widely recyclable or reusable, including eliminating all unnecessary plastics, where quality/safety permits by 2025 (Product Stewardship)
  • Increasing secondary and tertiary product package composition to 30% post-consumer recycled plastic content and 70% recycled content paper from sustainably managed forests by 2025 (Product Stewardship)